United States· US:85897-374_4d372a4d-ba8f-b8e4-e063-6294a90ae9d8
BODY / FACE SUNSCREEN SUN
A medicinal product containing homosalate; octinoxate, registered in United States by Guanghzou AiXin Biotech Co., Ltd.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HOMOSALATE; OCTINOXATE
- Manufacturer
- Guanghzou AiXin Biotech Co., Ltd
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1185897374015 BAG in 1 BOX (85897-374-01) / 1 CREAM, AUGMENTED in 1 BAG
- ndc1185897-374-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9a2e471-0d8a-4497-b815-6cb383aff559 GET /v1/drugs/b9a2e471-0d8a-4497-b815-6cb383aff559?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "CUTANEOUS",
"source": "ndc",
"strength": "7.5; 7.5",
"substance": "HOMOSALATE; OCTINOXATE",
"productndc": "85897-374",
"dosage_form": "CREAM, AUGMENTED",
"dea_schedule": null,
"strength_unit": "g/1; g/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about homosalate; octinoxate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.